Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Casale Donn — ARS Pharmaceuticals, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Casale Donn

Casale Donn

President at ARS Pharmaceuticals, Inc. · on record since Jun 1, 2026

Insider trading activity of Casale Donn

Transactions on record: 1; since Jul 2, 2026

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Jul 2, 2026

Figures computed from official regulatory filings — methodology.

Companies where Casale Donn has traded

ARS Pharmaceuticals, Inc.1 tx · Jul 2, 2026

Track record of Casale Donn

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Casale Donn

Co-insiders of Casale Donn

Alexandria Venture Investments, LLCARS Pharmaceuticals, Inc.
CAPPS VICKIE LARS Pharmaceuticals, Inc.
Chakma JustinARS Pharmaceuticals, Inc.
Dadoo RajeevARS Pharmaceuticals, Inc.
DEERFIELD MANAGEMENT CO /NYARS Pharmaceuticals, Inc.
Deerfield Mgmt III, L.P.ARS Pharmaceuticals, Inc.
Deerfield Mgmt IV, L.P.ARS Pharmaceuticals, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Deerfield Private Design Fund III, L.P.ARS Pharmaceuticals, Inc.

Deerfield Private Design Fund IV, L.P.ARS Pharmaceuticals, Inc.

Dorsey BrianARS Pharmaceuticals, Inc.

Duettra Jennifer DevonARS Pharmaceuticals, Inc.

Fitzpatrick Alexander AARS Pharmaceuticals, Inc.

Flynn James EARS Pharmaceuticals, Inc.

Hawkinson RussARS Pharmaceuticals, Inc.

HERSHBERG ROBERTARS Pharmaceuticals, Inc.

Hunder NaomiARS Pharmaceuticals, Inc.

Islam SaqibARS Pharmaceuticals, Inc.

Karas EricARS Pharmaceuticals, Inc.

KELLY MICHAELARS Pharmaceuticals, Inc.

Koehler MariaARS Pharmaceuticals, Inc.

Kolchinsky PeterARS Pharmaceuticals, Inc.

LEFF JONATHAN SARS Pharmaceuticals, Inc.

Loveless Barry DARS Pharmaceuticals, Inc.

Lowenthal Richard EARS Pharmaceuticals, Inc.

MAILANDER TAD MARS Pharmaceuticals, Inc.

MATULA TIMOTHYARS Pharmaceuticals, Inc.

Odegard ValerieARS Pharmaceuticals, Inc.

ORBIMED ADVISORS LLCARS Pharmaceuticals, Inc.

OrbiMed Capital GP VI LLCARS Pharmaceuticals, Inc.

ORBIMED CAPITAL LLCARS Pharmaceuticals, Inc.

Pepe Jeffrey C.ARS Pharmaceuticals, Inc.

Piazza JonathanARS Pharmaceuticals, Inc.

Powell Andrew Kenneth WilliamARS Pharmaceuticals, Inc.

Pratik Shah Living Trust dated June 15, 2011ARS Pharmaceuticals, Inc.

Presidio Management Group XII, L.L.C.ARS Pharmaceuticals, Inc.

RA Capital Biotech Fund LPARS Pharmaceuticals, Inc.

RA CAPITAL MANAGEMENT, LLCARS Pharmaceuticals, Inc.

RA Capital Nexus Fund II, L.P.ARS Pharmaceuticals, Inc.

ROOT JONATHAN DARS Pharmaceuticals, Inc.

SAUNDERS BRENT LARS Pharmaceuticals, Inc.

SCHNEIDER PHILLIP MARS Pharmaceuticals, Inc.

Schroeder ThiloARS Pharmaceuticals, Inc.

Scott Kathleen D.ARS Pharmaceuticals, Inc.

Shah PratikARS Pharmaceuticals, Inc.

Shah Rajeev M.ARS Pharmaceuticals, Inc.

Shawver LauraARS Pharmaceuticals, Inc.

Tanimoto SarinaARS Pharmaceuticals, Inc.

Tansey Casey MARS Pharmaceuticals, Inc.

Thompson James RichardARS Pharmaceuticals, Inc.

Thompson Peter AARS Pharmaceuticals, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
ARS Pharmaceuticals, Inc.	Jul 2, 2026	AwardD	898,456	0.00 USD	—	SEC